Stocks and Investing Stocks and Investing
Wed, April 16, 2014
Tue, April 15, 2014
Mon, April 14, 2014
Fri, April 11, 2014
Thu, April 10, 2014
Wed, April 9, 2014
Tue, April 8, 2014
Mon, April 7, 2014
Fri, April 4, 2014
Thu, April 3, 2014
Wed, April 2, 2014
Tue, April 1, 2014
Mon, March 31, 2014
Fri, March 28, 2014
Thu, March 27, 2014
Wed, March 26, 2014
Tue, March 25, 2014
Mon, March 24, 2014
Fri, March 21, 2014
Thu, March 20, 2014
Wed, March 19, 2014
Tue, March 18, 2014
Mon, March 17, 2014
Fri, March 14, 2014
Wed, March 12, 2014
Tue, March 11, 2014
Mon, March 10, 2014

Andrew Fein Initiated (BCRX) at Strong Buy and Held Target at $21 on, Mar 10th, 2014


Published on 2024-10-25 04:25:27 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Initiated "BioCryst Pharmaceuticals, Inc." (BCRX) at Strong Buy and Held Target at $21 on, Mar 10th, 2014.

Andrew has made no other calls on BCRX in the last 4 months.



There are 2 other peers that have a rating on BCRX. Out of the 2 peers that are also analyzing BCRX, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Justin Kim of "Oppenheimer" Initiated at Hold on, Thursday, February 27th, 2014


This is the rating of the analyst that currently disagrees with Andrew


  • Tazeen Ahmad of "B of A Securities" Downgraded from Hold to Sell on, Tuesday, January 28th, 2014